CD8A and neoplasm: The ratio of CD8+ IFN-γ+ to Tregs was dramatically elevated by the anti-4-1BB treatment in the tumor (Fig. 4g–i) and spleen (Supplementary Fig. 5) from CD73−/− group compared to other groups.